Advertisement

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x100px
Organisation › Details

Innovative Medicines Initiative (IMI JU + IMI2 JU)

The Innovative Medicines Initiative (IMI) is working to improve health by speeding up the development of, and patient access to, the next generation of medicines, particularly in areas where there is an unmet medical or social need. It does this by facilitating collaboration between the key players involved in healthcare research, including universities, pharmaceutical companies, other companies active in healthcare research, small and medium-sized enterprises (SMEs), patient organisations, and medicines regulators. This approach has proven highly successful, and IMI projects are delivering exciting results that are helping to advance the development of urgently-needed new treatments in diverse areas. IMI is a partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA). Through the IMI 2 programme, IMI has a budget of €3.3 billion for the period 2014-2020. Half of this comes from the EU’s research and innovation programme, Horizon 2020. The other half comes from large companies, mostly from the pharmaceutical sector; these do not receive any EU funding, but contribute to the projects ‘in kind’, for example by donating their researchers’ time or providing access to research facilities or resources. *

 

Period Start 2018-01-01 start
Period End 2021-11-30 renamed
  Group Innovative Health Initiative (IHI JU)
  Today Innovative Health Initiative (IHI JU)
  Successor Innovative Health Initiative (IHI JU)
Products Industry pharmaceutical
  Industry 2 drug discovery
     
Region Region EU (European Union)_oo
  Country EU (European Union)
  Street 56–60 Avenue de la Toison d’Or
  City 1060 Brussels
  Tel +32-2-221-8181
    Address record changed: 2024-01-05
     
Basic data Employees n. a.
     
    * Document for »About Section«: Innovative Medicines Initiative (IMI). (5/12/20). "Press Release: IMI Announces COVID Projects, Boosts Funding Pot to EUR 72 million". Brussels.
     
   
Record changed: 2023-07-15

Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm from 14 Sep 650x200px

More documents for Innovative Health Initiative (IHI JU)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top